Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-10-20

FDA Approved: ALBENDAZOLE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Albendazole submitted by Amneal Pharmaceuticals of New York LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albendazole (ALBENDAZOLE)

Snippet

SUPPL AP for ALBENDAZOLE (ALBENDAZOLE)